The impact of ABCB1 and CES1 polymorphisms on the safety of dabigatran in patients with non-valvular atrial fibrillation
Abstract Background This study aimed to analyze associations between genetic variants and plasma concentrations along with clinical outcomes in dabigatran in patients with non-valvular atrial fibrillation (NVAF). Methods We conducted a prospective study and enrolled NVAF patients treated with dabiga...
Enregistré dans:
| Auteurs principaux: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
BMC
2022-11-01
|
| Collection: | BMC Cardiovascular Disorders |
| Sujets: | |
| Accès en ligne: | https://doi.org/10.1186/s12872-022-02910-4 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|